CN1236798C - External medicine for treating bone tuberculosis - Google Patents
External medicine for treating bone tuberculosis Download PDFInfo
- Publication number
- CN1236798C CN1236798C CN 200410013704 CN200410013704A CN1236798C CN 1236798 C CN1236798 C CN 1236798C CN 200410013704 CN200410013704 CN 200410013704 CN 200410013704 A CN200410013704 A CN 200410013704A CN 1236798 C CN1236798 C CN 1236798C
- Authority
- CN
- China
- Prior art keywords
- bone tuberculosis
- present
- medicine
- tuberculosis
- external use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 206010056377 Bone tuberculosis Diseases 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 208000009360 Osteoarticular Tuberculosis Diseases 0.000 title claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 6
- QYZBCWXZSYTIOY-UHFFFAOYSA-N Mercuric oxide Chemical compound [O-2].[Hg+2] QYZBCWXZSYTIOY-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229940040145 liniment Drugs 0.000 claims description 7
- 239000000865 liniment Substances 0.000 claims description 7
- 241001161070 Calomela Species 0.000 claims description 5
- 241001057584 Myrrha Species 0.000 claims description 5
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 5
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims description 5
- 239000009286 sanguis draxonis Substances 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 231100000614 poison Toxicity 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 206010052428 Wound Diseases 0.000 abstract description 6
- 208000027418 Wounds and injury Diseases 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 6
- 239000003440 toxic substance Substances 0.000 abstract description 6
- 208000002193 Pain Diseases 0.000 abstract description 5
- 210000000988 bone and bone Anatomy 0.000 abstract description 5
- 239000011505 plaster Substances 0.000 abstract description 5
- 230000029663 wound healing Effects 0.000 abstract description 5
- 241000193830 Bacillus <bacterium> Species 0.000 abstract description 3
- 239000000843 powder Substances 0.000 abstract description 3
- 230000017423 tissue regeneration Effects 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 abstract description 2
- 230000002980 postoperative effect Effects 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 abstract description 2
- 230000008929 regeneration Effects 0.000 abstract 2
- 238000011069 regeneration method Methods 0.000 abstract 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 241000219061 Rheum Species 0.000 abstract 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 abstract 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 abstract 1
- 229940037003 alum Drugs 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- NWFNSTOSIVLCJA-UHFFFAOYSA-L copper;diacetate;hydrate Chemical compound O.[Cu+2].CC([O-])=O.CC([O-])=O NWFNSTOSIVLCJA-UHFFFAOYSA-L 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- XMFOQHDPRMAJNU-UHFFFAOYSA-N lead(ii,iv) oxide Chemical compound O1[Pb]O[Pb]11O[Pb]O1 XMFOQHDPRMAJNU-UHFFFAOYSA-N 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000002994 raw material Substances 0.000 abstract 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 abstract 1
- 230000008961 swelling Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 201000008827 tuberculosis Diseases 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008468 bone growth Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- 206010056367 Joint tuberculosis Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000001294 Nociceptive Pain Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 210000002310 elbow joint Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses an external use medicine for treating bone tuberculosis, which is prepared from raw material medicines of the weight proportioning: 5 to 10 g of caiomelas, 5 to 10 g of hydrargyri oxydum rubrum, 15 to 20 g of rosin, 15 to 25 g of lead orthoplumbate, 10 to 15 g of dragon blood, 5 to 10 g of borneol, 10 to 15 g of vermilion, 10 to 15 g of verdigris, 10 to 15g of myrrh, 5 to 10 g of alum and 5 to 10 g of rhubarb, the medicines are ground into fine powder which is smeared to wound positions to be completely covered on wound surfaces. The external use plaster for removing toxic substances matched with oral administration Chinese herbal medicines can treat various types of bone tuberculosis, can treat scrofula, mouse sore and various types of sore symptoms, and can also be used for promoting postoperative wound healing. The medicine of the present invention has the efficiency of removing putrefaction, closing sores, removing toxic substances, promoting tissue regeneration, eliminating bumps and relieving pain, and can quickly relieve inflammation, sterilize, detoxicate, promote tissure regeneration, eliminate putridity and promote new tissues regeneration to achieve the aims that tubercle bacillus are killed, the resorption of dead bones and pus are promoted, new bones are grown and repaired, and diseases are thoroughly cured. The external use medicine for treating bone tuberculosis of the present invention has the advantages of simple manufacturing process and low price, and the cure rate can reach 100%.
Description
Technical field
The present invention relates to a kind of liniment for the treatment of bone tuberculosis, belong to the field of Chinese medicines.
Background technology
Bone tuberculosis is to invade bone or joint and the suppurative destructive pathological changes that causes by tubercule bacillus, because of it is fallen ill in bone or joint, consumes qi-blood-body fluid, and it is thin to cause the later stage body to be won, and healthy energy decays, touching difficulty more, so a bone tuberculosis.Bone tuberculosis is intractable difficult and complicated illness clinically, at present, though the Chinese and western drugs and the method for some treatment bone tuberculosis are arranged, effectively early stage, but in having entered when most patients make a definite diagnosis, late period, the osteoarthrosis focus is destroyed serious, because local coagulation of QI-blood is obstructed, and the microcirculation serious hindrance, so effectively antituberculotics is difficult to reach affected area by circulation, most patient's curative effects are very poor, and the tuberculosis Western medicine is all to liver, kidney, intestinal and neural toxic and side effects are big, so that the part patient is difficult to adhere to medication on schedule, need operative treatment when this disease is serious, this therapy not only patient is expensive high, and general family is difficult to payment, and painful big, dangerous big, success rate is low, the relapse rate height, and be difficult to radical cure.
Summary of the invention
The object of the invention is to provide a kind of liniment that can effectively treat bone tuberculosis, and it adopts inner disease outer treat, inside and outside the method treatment bone tuberculosis of ruling together, cooperate Chinese herbal medicine for oral administration and dial malicious plaster, cure rate reaches 100%.
The crude drug that the present invention selects, is held back skin ulcer, the toadstool in can boning at Calomelas parasite killing, counteracting toxic substances; Hydrargyri Oxydum Rubrum is drawn out pus by applying a plaster to the affected part, is removed pus, removing the necrotic tissue and promoting granulation, but the toadstool in the fleshing; Vermilion has the effect of dialling poison; The Aerugo rust of can boning; The Colophonium granulation promoting is put on flesh, and waterproof relieves the pain; The Sanguis Draxonis hemostasis, promoting tissue regeneration and wound healing; The Myrrha granulation promoting is put on flesh, reducing swelling and alleviating pain; The Plumbum preparatium removing toxic substances that dispels the wind, reducing swelling and alleviating pain, blood circulation promoting and blood stasis dispelling; Alumen detoxifcation parasite killing, removing dampness is held back skin ulcer, and hemostasisization is rotten; The Borneolum Syntheticum removing toxic substances and promoting subsidence of swelling, removing the necrotic tissue pain relieving, promoting tissue regeneration and wound healing; The Radix Et Rhizoma Rhei heat-clearing and toxic substances removing, dispersing swelling and dissipating binds.The all medicines of the present invention share, and bring out the best in each other, and have putrefaction removing and hold back skin ulcer, dial taking poison and growing muscle due, the effect of reducing swelling and alleviating pain.Fast anti-inflammation and sterilization, detoxification granulation promoting, remove the rotten and let fresh grow, kill tubercule bacillus thereby reach, promote pus and sequestrum to absorb, new bone growth reparation, the thoroughly purpose of cure diseases.
The technical scheme that the present invention treats the liniment of bone tuberculosis is: crude drug and weight proportion are: Calomelas 5～10g, Hydrargyri Oxydum Rubrum 5～10g, Colophonium 15～20g, Plumbum preparatium 15～25g, Sanguis Draxonis 10～15g, Borneolum Syntheticum 5～10g, Vermilion 10～15g, Aerugo 10～15g, Myrrha 10～15g, Alumen 5～10g, Radix Et Rhizoma Rhei 5～10g.
Be preferably: Calomelas 5g, Hydrargyri Oxydum Rubrum 5g, Colophonium 15g, Plumbum preparatium 25g, Sanguis Draxonis 10g, Borneolum Syntheticum 5g, Vermilion 15g, Aerugo 10g, Myrrha 10g, Alumen 10g, Radix Et Rhizoma Rhei 10g.
The preparation method of bone tuberculosis external application for curing medicine of the present invention is: said medicine is ground into fine powdered.Using method: powder is applied to the wound, is as the criterion, and external application is dialled malicious plaster, every day 1 time to cover wound face fully.
The present invention treats the liniment of bone tuberculosis, and preparation technology is simple, and is cheap, pure Chinese medicinal preparation has no side effect, the misery of having avoided patient to take medicine for a long time, have an injection and perform the operation, and medicine of the present invention is by the lesions position osmotic absorption, but infiltrate osseous tissue within a short period of time, play a role.The present invention has stronger anti-consumptive disease sterilization, blood stasis dispersing and fresh blood promoting, and short new bone growth improves function of joint, and the present invention can be used for treating various bone tuberculosis, also can treat lymphoid tuberculosis, scrofula and various skin ulcer disease, also can be used for postoperative wound healing.
The specific embodiment
Further set forth the beneficial effect of medicine of the present invention by clinical trial.
1, general case is selected: treat 38 routine bone tuberculosis patients, male's 15 examples, women's 23 examples, 42 years old mean age.Tuberculosis of spine 20 examples wherein; Tuberculosis of knee joint 7 examples; Coxodynia 6 examples; Tuberculosis of elbow joint 4 examples; Tuberculosis of ankle joint 1 example.
2, diagnostic criteria: according to medical history, symptom, sign, chemical examination and x ray examination, bacteriology and pathological examination.
3, Therapeutic Method: powder is applied to the wound, is as the criterion, and external application dials malicious plaster, get final product for 1 time every day to cover wound face fully.
4, curative effect determinate standard: 1. recovery from illness: refer to the complete obiteration of whole body disease, wound healing, the elimination of swelling and ache reaches the clinical cure standard.2. take a turn for the better: refer to that general symptom is significantly improved, still in treatment.3. invalid: as to refer to medication after one month, whole body and local no any improver.
5, result: through treatment, 38 routine patients all reach the recovery from illness standard, and cure rate 100% is wherein treated month cured person 4 examples, treats three months cured person 8 examples, treats six months cured person 26 examples.
Claims (2)
1, a kind of liniment for the treatment of bone tuberculosis, it is characterized in that: crude drug and weight proportion are: Calomelas 5～10g, Hydrargyri Oxydum Rubrum 5～10g, Colophonium 15～20g, Plumbum preparatium 15～25g, Sanguis Draxonis 10～15g, Borneolum Syntheticum 5～10g, Vermilion 10～15g, Aerugo 10～15g, Myrrha 10～15g, Alumen 5～10g, Radix Et Rhizoma Rhei 5～10g, pulverize gets final product.
2, a kind of liniment for the treatment of bone tuberculosis according to claim 1, it is characterized in that: crude drug and weight proportion are: Calomelas 5g, Hydrargyri Oxydum Rubrum 5g, Colophonium 15g, Plumbum preparatium 25g, Sanguis Draxonis 10g, Borneolum Syntheticum 5g, Vermilion 15g, Aerugo 10g, Myrrha 10g, Alumen 10g, Radix Et Rhizoma Rhei 10g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410013704 CN1236798C (en) | 2004-04-20 | 2004-04-20 | External medicine for treating bone tuberculosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410013704 CN1236798C (en) | 2004-04-20 | 2004-04-20 | External medicine for treating bone tuberculosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1562134A CN1562134A (en) | 2005-01-12 |
| CN1236798C true CN1236798C (en) | 2006-01-18 |
Family
ID=34478260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410013704 Expired - Fee Related CN1236798C (en) | 2004-04-20 | 2004-04-20 | External medicine for treating bone tuberculosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1236798C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104208329A (en) * | 2014-08-15 | 2014-12-17 | 王军 | Traditional Chinese medicine patch used for treatment of sore and ulcer disease |
| CN105194220A (en) * | 2015-10-15 | 2015-12-30 | 张士海 | External application preparation for treating bone tuberculosis and preparation method |
-
2004
- 2004-04-20 CN CN 200410013704 patent/CN1236798C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1562134A (en) | 2005-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101214286B (en) | Chinese medicine white spirit preparations for effectively treating rheumatic pain diseases | |
| CN101361872A (en) | Traditional Chinese medicine for quickly treating bone fracture and postoperative nonunion and delayed healing | |
| CN103566071B (en) | Traditional Chinese medicine composition for treating ulcer and preparation method of powder of traditional Chinese medicine composition | |
| CN112618646A (en) | Traditional Chinese medicine composition and traditional Chinese medicine oil for treating burns and preparation method thereof | |
| CN103520633B (en) | Processing method of anticancer blood-circulation activating and mass disintegrating ointment | |
| CN1085797A (en) | Eliminating inflammation and expelling toxin sore treatment ointment and preparation method thereof | |
| CN102824449B (en) | A kind of external-use tincture for the treatment of decubital ulcer, traumatic infection, diabetic dermopathy | |
| CN1074676C (en) | Medicine for treating rheumatic arthritis and hyperosteogeny and preparing process thereof | |
| CN1176709C (en) | Drug for curing scald, hrut and inflammations as well as hemorrhoids | |
| CN1189197C (en) | Traditional Chinese medicine having effects of reducing inflammation, stopping blooding, stopping pain, promoting blood circulation and promoting tissue regeneration | |
| CN102988555A (en) | Skin and tissue cream for burns | |
| CN1236798C (en) | External medicine for treating bone tuberculosis | |
| CN1281228C (en) | Medicine for hyperplasia of mammary glands and its preparation | |
| CN1068785C (en) | Chinese patent medicine for external application for curing diseases of scald, burn and dermal ulcer | |
| CN101810668A (en) | Toxin drawing plaster | |
| CN108392572B (en) | Plaster for removing stasis, promoting tissue regeneration, healing sore and relieving pain and preparation method and application thereof | |
| CN100413514C (en) | Pigeon leaf medicinal material and its extract, preparation and use thereof | |
| CN101274047B (en) | External-use ointment for treating burn and method of preparing the same | |
| CN1289120C (en) | Plaster for treating infantile hernia and initial stage lymphoid tuberculosis | |
| CN104524471A (en) | Detumescent and acesodyne ointment | |
| CN109529022A (en) | A kind of diabetic foot wound externally applied drug and its application method | |
| CN1141967C (en) | Externally applied Chinese medicine oil prepn for treating burns and scalds | |
| CN100335079C (en) | Oral Chinese medicine preparation of caput femoris ischemic necrosis and production thereof | |
| CN1298371C (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof | |
| CN101259200A (en) | Orally-administered and externally-applied specific medicine for treating bone injury disease, protrusion of lumbar intervertebral discs and wrick |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |